Araki E, Mathieu C, Shiraiwa T, Maeda H, et al. Long-term (52-week) efficacy and safety of dapagliflozin as adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study. Diabetes Obes Metab 2021 Feb 23. doi: 10.1111/dom.14362.
PMID: 33620762